)
Jeffrey Rona
Chief Business and Financial Officer
Ovid Therapeutics
Jeffrey Rona is the chief business and financial officer at Ovid. He is responsible for leading Ovid’s corporate strategy along with the Company’s capital formation with investor groups. Mr. Rona joined Ovid as consulting chief financial officer in 2019 to assist the Company with strategic financings, including Ovid’s collaboration with Angelini. He brings more than 25 years of experience to the role, both as a former investment banker and a strategic financial executive with expertise in financial operations, investor relations and raising capital for public and private companies. He previously held senior leadership positions for GlobeImmune (NASDAQ: GMIB), AlgoRx Pharmaceuticals and Antigenics (NASDAQ: AGEN), and later formed a successful life sciences financial advisory practice. Mr. Rona began his career at Coopers & Lybrand and UBS Investment Bank (NYSE: UBS). He holds a Bachelor of Science in Accounting from Case Western Reserve University.
Sessions
-
22-Jun-202630ABCBetting Bold: How Smart Deals Build Biotech
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}